Do I Need HRT? How to Tell If Hormone Therapy Is Right for You

Do I need HRT? The honest answer

HRT, now often called menopause hormone therapy, is a treatment you choose. It is not a verdict a lab hands you.

Your prescriber won't check one hormone level and announce that you need it. The decision rests on how much your symptoms bother you, how far you are from your last period, and what your health history says.

If your symptoms are mild and life runs as usual, skipping HRT is a sound choice. If hot flashes wreck your nights or your workday, it is the strongest tool there is. The Menopause Society calls it the most effective treatment for hot flashes and night sweats.

There is one real exception. If your periods stop before 45, and especially before 40, losing estrogen that early raises the risk of bone loss and heart disease. Hormone therapy is then usually advised as a health measure, not only for comfort. The section on early menopause below explains why.

Everyone else gets a genuine choice. Saying no, or not yet, is a legitimate outcome, and there is a real plan B further down.

Signs you need HRT: what hormones treat well, and what they don't

The clearest sign is a symptom HRT is proven to treat, and that symptom is making your days or nights harder. Here is what the evidence supports.

Where HRT clearly helps

• Hot flashes and night sweats. Doctors call these vasomotor symptoms. The Menopause Society's 2022 position statement names HRT as the most effective treatment for them.
• Sleep broken by night sweats. If drenching sweats are what wake you, treating them goes after the cause of the broken nights. Insomnia with no night sweats behind it is a different problem.
• Vaginal dryness and painful sex. These belong to the genitourinary syndrome of menopause, or GSM, meaning vaginal and urinary changes that follow the drop in estrogen. HRT is the most effective treatment here too.
• GSM on its own. If dryness is your only problem, low-dose vaginal estrogen is often enough. The Menopause Society recommends it when over-the-counter moisturizers and lubricants don't help.
• Bone loss. The Menopause Society says HRT prevents bone loss and fractures. FDA labels add a limit: if bones are the only goal, non-estrogen medicines should be considered first.
• Low mood in perimenopause, with care. 2018 guidelines from The Menopause Society and a depression-center task group found evidence that estrogen eases depression in perimenopause, especially alongside hot flashes. They also note that estrogen is not FDA-approved to treat depression.

What HRT is not for

• Protecting your heart. The FDA and The Menopause Society do not recommend HRT to prevent heart disease. The US Preventive Services Task Force also advises against hormone therapy to prevent chronic conditions.
• Preventing dementia. The Menopause Society does not recommend HRT to prevent dementia. It lists dementia among the risks that rise when HRT starts after 60.
• Losing weight. A Cochrane review found HRT had no effect on body weight. It neither added pounds beyond normal midlife gain nor took them off.
• Building muscle. The Menopause Society's 2022 statement lists hot flashes, vaginal and urinary symptoms and bone loss as the reasons to use HRT. Muscle is not on that list.

If your main hope is a stronger heart or a slimmer waist, HRT is the wrong tool. If it's quieter nights, it may be exactly the right one. Our guide to HRT benefits and risks goes through each benefit in depth.

How do I know if I need HRT if no test can tell me?

Mayo Clinic puts it plainly: tests most often aren't needed to diagnose menopause. Past 45, your age and your symptoms usually tell the story.

Hormone levels swing from week to week in perimenopause, the years of change before the final period. One reading can look normal on a bad day. Mayo Clinic also says home FSH urine tests can't really tell you whether you're in menopause.

Blood tests do help in a few situations.

• You're under 45. Tests help check for early menopause, which changes the advice.
• Thyroid trouble is possible. A TSH test checks the thyroid, which can cause sweats, fatigue and mood changes of its own.
• You're exhausted. A blood count can spot anemia, a shortage of red blood cells that also drains energy.
• Low mood is the main problem. That calls for a depression screen, a short questionnaire rather than a lab test.

The most useful test is one you run yourself. Keep a symptom log for two weeks before you decide.

• Count hot flashes. Note how many you get each day and how strong they feel.
• Track nights. Write down how often you wake, and whether sweating woke you.
• Rate the impact. Score how much symptoms affected work, mood and plans that day.
• Note your periods. Record dates and changes in flow.
• Flag anything new. Vaginal dryness, urinary urgency, joint aches or low mood.

A log turns a vague feeling into something you and a prescriber can weigh. Our perimenopause quiz helps you sort your symptoms first. The perimenopause test guide and the guide to perimenopause labs explain which tests are worth doing.

When to start HRT: why the 10-year window matters

Timing shapes the balance more than almost anything else. The Menopause Society's 2022 position statement finds the balance favorable for women under 60, or within 10 years of menopause, who have no medical reason to avoid HRT.

Starting later looks less favorable. The absolute risks of heart disease, stroke, blood clots and dementia are higher in that group.

The FDA labels now carry the same timing advice. The Divigel label updated in February 2026 tells prescribers to consider starting it in women younger than 60 or less than 10 years past menopause.

The FDA's February 2026 announcement went further. It cited research linking an early start, within 10 years of menopause and generally before 60, to fewer fractures and lower death rates overall.

You don't have to wait for your last period. Many women start during perimenopause, often with a different form or schedule. Our guide to hormone therapy in perimenopause covers that window.

Past 60, the answer becomes individual rather than an automatic no. Continuing HRT you started earlier is a different question from starting fresh. Our guide on how to start HRT explains what changes after 60.

Who should not take HRT

Every estrogen label lists contraindications, meaning medical reasons not to use the drug. This list follows the Divigel label updated in February 2026.

• Unexplained vaginal bleeding. It must be checked first, because it can signal a problem in the lining of the uterus.
• Breast cancer now or in the past.
• Other cancers that estrogen can fuel.
• A blood clot in a leg or lung, now or in the past.
• A stroke or heart attack, now or in the past.
• Liver disease or poor liver function.
• An inherited clotting disorder. Examples include protein C, protein S or antithrombin deficiency.
• A past serious allergic reaction to the product.

The route matters for clot risk. The Menopause Society says patches, gels and lower doses may carry a lower risk of clots and stroke than pills.

A careful choice, not an automatic no

• Breast cancer in your family. A mother's or sister's breast cancer is not on the label's list. It is a reason to look closely at your own risk, sometimes with a genetic counselor.
• A BRCA gene change. A 2014 review found that short-term HRT after ovary removal did not seem to worsen cancer outcomes in carriers without breast cancer. Its authors called for larger trials.
• Migraine with aura. It raises stroke risk on its own, so mention it.
• High heart risk. High blood pressure, diabetes or high cholesterol weigh more heavily the older you are when you start.
• Smoking. It adds its own clot and heart risk on top of anything HRT carries.

This is the one area where your own clinician's reading of your history matters more than any article. Our guide to HRT benefits and risks has the full risk tables to bring to that talk.

Early menopause or POI: here the answer is usually yes

Early menopause means periods stop for good before 45. Before 40 it is called premature ovarian insufficiency, or POI, meaning the ovaries slow down early.

A 2024 international guideline, co-written by the American Society for Reproductive Medicine, sets two criteria for POI. FSH is a hormone that rises as the ovaries wind down.

• Your cycles. Periods have been irregular or absent for at least 4 months.
• One blood test. A single FSH result is above 25 IU/L.

POI is more common than once thought. The guideline puts it at about 3.5% of women.

Losing estrogen this early raises the risk of bone loss and heart disease. The guideline recommends hormone therapy until the usual age of menopause, then a fresh look at the balance.

The Menopause Society agrees for early menopause too. It says hormone therapy can be used until at least the average age of menopause, unless there is a medical reason not to.

Is HRT right for me? Weighing the real risks, and what the FDA changed in 2026

Risk depends on the type of hormone, the dose, the route, when you start and whether a progestogen is included. The Menopause Society treats each of these as part of the choice.

The best numbers come from the Women's Health Initiative, or WHI, a set of large US trials. A 2013 analysis in JAMA used a combined score of serious events, including heart disease, stroke, blood clots, breast cancer, hip fracture and death.

For women aged 50 to 59 on combined estrogen and progestin pills, that score showed about 12 extra events per 10,000 women each year.

Put another way, that is roughly one extra serious event per 1,000 women a year.

For women in their 50s on estrogen alone, after a hysterectomy, the same score showed about 19 fewer events per 10,000 women each year.

The picture shifted with age. In women aged 70 to 79, combined pills showed about 38 extra events per 10,000 women each year.

The authors concluded that HRT should not be used to prevent chronic disease, but may suit some women for symptom relief. The USPSTF reached the same view on prevention in 2022 and noted that its advice does not cover symptom treatment.

On February 12, 2026, the FDA approved new labels for six hormone therapy products. Heart disease, breast cancer and probable dementia came off the boxed warning, the strongest alert a drug label carries.

Not everything went. On estrogen-only products such as Divigel, the box still warns about cancer of the uterus lining when estrogen is used without a progestogen. Heart disease and breast cancer are still covered in the label's warnings section.

Labels are being updated product by product. The leaflet in your box may show the older wording for a while.

For the full risk tables, route by route, read HRT benefits and risks. To compare patches, gels and pills, see the best HRT for menopause.

Can I try HRT and stop if I don't like it?

Yes. Many women treat the first prescription as a trial, and that is a reasonable way to decide.

The FDA patient leaflets ask you and your prescriber to talk regularly about whether you still need it. They give every 3 to 6 months as an example.

At that review you weigh three things. How much your symptoms changed, any side effects that lingered, and any bleeding pattern.

Early effects such as breast tenderness or bloating often settle as your body adjusts. Our guide to HRT side effects explains which ones fade and which are worth a call.

There is no fixed end date either. The Menopause Society asks that longer use rest on a clear reason, such as hot flashes that persist, plus regular reevaluation. If you stop, hot flashes can come back.

Our guide on how to start HRT walks through the first 90 days, from the first visit to the first follow-up.

If HRT isn't for you: what else works

Choosing not to take hormones still leaves real options. The Menopause Society's 2023 nonhormone position statement recommends these for hot flashes.

• Cognitive behavioral therapy. CBT is a short course of talk therapy that changes how you respond to symptoms.
• Clinical hypnosis. Guided sessions with a trained therapist.
• Weight loss. The statement lists it as an option for hot flashes.
• SSRIs and SNRIs. These are antidepressant families. Low-dose paroxetine, sold as Brisdelle, is FDA-approved for hot flashes.
• Gabapentin. A nerve medicine that the statement also recommends.
• Fezolinetant, sold as Veozah. A pill made to target the brain signal behind hot flashes.
• Elinzanetant, sold as Lynkuet. A newer pill of the same kind, approved by the FDA on October 24, 2025, after the statement came out.
• Oxybutynin. A bladder medicine that the statement also recommends for hot flashes.
• Stellate ganglion block. An injection near a nerve cluster in the neck.

The same statement does not recommend exercise, yoga, diet changes, cooling tricks or herbal supplements for hot flashes. They may help your health or comfort in other ways, but the evidence doesn't show they cut hot flashes.

If vaginal dryness is your only issue, you may not need systemic HRT at all. Low-dose vaginal estrogen works locally, and The Menopause Society also lists vaginal DHEA and ospemifene, a non-estrogen pill, as alternatives.

Our guide to menopause treatment options compares every choice. For a head-to-head look, read Veozah vs HRT.

What if my doctor says I don't need HRT?

Start by asking what specifically rules you out. A clear answer, such as a past stroke, is worth hearing. A vague worry rooted in old headlines is worth questioning.

A second opinion is a normal step, not a confrontation. The Menopause Society runs a practitioner directory that lists its members and Menopause Society Certified Practitioners, called MSCPs, who have passed its certification exam.

Telehealth is another door. Online menopause services can review your history by video or written visit and prescribe when it fits.

Our guides to finding menopause care and finding an HRT doctor cover how to ask, and what to say if you're turned down.

Questions to ask your doctor before deciding on HRT

Bring your symptom log and these questions. Write the answers down, because the details blur once you leave.

• Fit. Based on my symptoms, is HRT likely to help me more than the alternatives?
• Timing. Where am I relative to the 10-year window, and does that change the risk for me?
• History. Is anything in my history a reason to avoid it, or just a reason to choose carefully?
• Route. Would a patch or gel suit me better than a pill?
• Uterus. Do I need a progestogen, and which schedule would you suggest?
• Goal. Which symptom should improve first, and how will we judge it?
• Review. When do we check in, and what would make us change or stop?
• Plan B. If HRT isn't right for me, which non-hormonal option would you try first?
• Cost. Is my prescription covered, and what will I pay each month? Our guide to HRT and insurance explains what plans usually cover.